Keiki Oikawa, Shin-ichiro Ohno, Kana Ono, Kaito Hirao, Ayano Murakami, Yuichirou Harada, Katsuyoshi Kumagai, Katsuko Sudo, Masakatsu Takanashi, Akio Ishikawa, Shouichirou Mineo, Koji Fujita, Tomohiro Umezu, Noriko Watanabe, Yoshiki Murakami, Shinichiro Ogawa, Kris Ann Schultz, Masahiko Kuroda
求助PDF
{"title":"肝脏特异性 DICER1 综合征模型小鼠会出现原发性纤毛缺陷的囊性肝肿瘤。","authors":"Keiki Oikawa, Shin-ichiro Ohno, Kana Ono, Kaito Hirao, Ayano Murakami, Yuichirou Harada, Katsuyoshi Kumagai, Katsuko Sudo, Masakatsu Takanashi, Akio Ishikawa, Shouichirou Mineo, Koji Fujita, Tomohiro Umezu, Noriko Watanabe, Yoshiki Murakami, Shinichiro Ogawa, Kris Ann Schultz, Masahiko Kuroda","doi":"10.1002/path.6320","DOIUrl":null,"url":null,"abstract":"<p>DICER1 syndrome is a tumor predisposition syndrome caused by familial genetic mutations in <i>DICER1</i>. Pathogenic variants of <i>DICER1</i> have been discovered in many rare cancers, including cystic liver tumors. However, the molecular mechanisms underlying liver lesions induced by these variants remain unclear. In the present study, we sought to gain a better understanding of the pathogenesis of these variants by generating a mouse model of liver-specific DICER1 syndrome. The mouse model developed bile duct hyperplasia with fibrosis, similar to congenital hepatic fibrosis, as well as cystic liver tumors resembling those in Caroli's syndrome, intrahepatic cholangiocarcinoma, and hepatocellular carcinoma. Interestingly, the mouse model of DICER1 syndrome showed abnormal formation of primary cilia in the bile duct epithelium, which is a known cause of bile duct hyperplasia and cyst formation. These results indicated that <i>DICER1</i> mutations contribute to cystic liver tumors by inducing defective primary cilia. The mouse model generated in this study will be useful for elucidating the potential mechanisms of tumorigenesis induced by <i>DICER1</i> variants and for obtaining a comprehensive understanding of DICER1 syndrome. © 2024 The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"264 1","pages":"17-29"},"PeriodicalIF":5.6000,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Liver-specific DICER1 syndrome model mice develop cystic liver tumors with defective primary cilia\",\"authors\":\"Keiki Oikawa, Shin-ichiro Ohno, Kana Ono, Kaito Hirao, Ayano Murakami, Yuichirou Harada, Katsuyoshi Kumagai, Katsuko Sudo, Masakatsu Takanashi, Akio Ishikawa, Shouichirou Mineo, Koji Fujita, Tomohiro Umezu, Noriko Watanabe, Yoshiki Murakami, Shinichiro Ogawa, Kris Ann Schultz, Masahiko Kuroda\",\"doi\":\"10.1002/path.6320\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>DICER1 syndrome is a tumor predisposition syndrome caused by familial genetic mutations in <i>DICER1</i>. Pathogenic variants of <i>DICER1</i> have been discovered in many rare cancers, including cystic liver tumors. However, the molecular mechanisms underlying liver lesions induced by these variants remain unclear. In the present study, we sought to gain a better understanding of the pathogenesis of these variants by generating a mouse model of liver-specific DICER1 syndrome. The mouse model developed bile duct hyperplasia with fibrosis, similar to congenital hepatic fibrosis, as well as cystic liver tumors resembling those in Caroli's syndrome, intrahepatic cholangiocarcinoma, and hepatocellular carcinoma. Interestingly, the mouse model of DICER1 syndrome showed abnormal formation of primary cilia in the bile duct epithelium, which is a known cause of bile duct hyperplasia and cyst formation. These results indicated that <i>DICER1</i> mutations contribute to cystic liver tumors by inducing defective primary cilia. The mouse model generated in this study will be useful for elucidating the potential mechanisms of tumorigenesis induced by <i>DICER1</i> variants and for obtaining a comprehensive understanding of DICER1 syndrome. © 2024 The Pathological Society of Great Britain and Ireland.</p>\",\"PeriodicalId\":232,\"journal\":{\"name\":\"The Journal of Pathology\",\"volume\":\"264 1\",\"pages\":\"17-29\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2024-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/path.6320\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Pathology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/path.6320","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用